# US 2013/0253071 A1 · Methods and Compositions for Prevention and Treatment of Inflammatory Disease, Autoimmune Disease and Transplant Rejection

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0253071 A1
- Document ID: US20130253071A1
- Status: Published application
- Kind: A1
- Application number: 13/804,820
- Filed: 2013-03-14
- Published: 2013-09-26
- Earliest claimed: 2001-11-02
- Assignees: The Regents of the University of California
- Applicants: The Regents of the University of California
- Inventors: Michael David
- Web page: https://patentgrep.com/patent/US20130253071A1

## CPC

- A61K 31/05: Phenols {(cannabinoids A61K31/658)}
- A61K 31/085: having an ether linkage to aromatic ring nuclear carbon
- A61K 31/09: having two or more such linkages
- A61K 31/135: having aromatic rings {, e.g. ketamine, nortriptyline (methadone A61K31/137)}
- A61K 31/70: Carbohydrates; Sugars; Derivatives thereof (sorbitol A61K31/047)
- A61K 31/7028: Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K 31/704: attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin {(digitoxin A61K31/7048)}
- A61P 1/00: Drugs for disorders of the alimentary tract or the digestive system
- A61P 11/06: Antiasthmatics
- A61P 25/00: Drugs for disorders of the nervous system
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P 31/00: Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P 37/02: Immunomodulators
- A61P 37/06: Immunosuppressants, e.g. drugs for graft rejection
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The invention provides compositions and methods for reducing one or more symptoms of an autoimmune disease, inflammatory disease, and/or transplant rejection, by the administration to a subject in need thereof a pharmaceutically effective amount of a purified compound of any one of Formulae A-E. The invention's methods are useful for the prevention, amelioration, and treatment of autoimmune disease, inflammatory disease, and/or transplant rejection.

## Claims

### Claim at position 1

1-39. (canceled)

### Claim 40

A method for reducing one or more symptoms of asthma in a subject in need thereof, wherein said method comprises administering to said subject a pharmaceutically effective amount of purified piceatannol, wherein said subject is selected from the group consisting of human, mouse and canine.

### Claim 41 (depends on 40)

The method of claim 40, wherein said administering is intranasal.

### Claim 42 (depends on 40)

The method of claim 40, wherein said administering is before manifestation of one or more symptoms of asthma.

### Claim 43 (depends on 40)

The method of claim 40, wherein said administering is concomitant with manifestation of one or more symptoms of asthma.

### Claim 44 (depends on 40)

The method of claim 40, wherein said administering is after manifestation of one or more symptoms of asthma.
